Skip to main content
. 2019 Dec 2;122(3):333–339. doi: 10.1038/s41416-019-0582-7

Table 4.

Efficacy Measures Stratified by Line of Therapy

Outcome Controls (N = 52) Mut-positive (N = 26) P-value
Real-world progression free survival by line of therapy (mo)
 First 7.9 21.1 0.0046
 Second or later 3.4 2.5 0.43
Overall response rate by line of therapy—no. with response/no. evaluable (%)
 First 8/28 (29) 13/19 (68) 0.007
 Second or later 0/11 (0) 1/5 (20) 0.12

A subset analysis to compare ORR and rwPFS by line of therapy in which platinum-based treatment was initiated was performed